ID   FRPD2_HUMAN             Reviewed;        1309 AA.
AC   Q68DX3; B7WNW0; B7ZML5; Q2VY07; Q6GMQ9; Q6ZN38; Q6ZWI2; Q8N5T9;
DT   02-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   31-MAY-2011, sequence version 3.
DT   28-JUN-2023, entry version 167.
DE   RecName: Full=FERM and PDZ domain-containing protein 2;
DE   AltName: Full=PDZ domain-containing protein 4;
DE   AltName: Full=PDZ domain-containing protein 5C;
GN   Name=FRMPD2; Synonyms=PDZD5C, PDZK4, PDZK5C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5).
RA   Xu J., Xie Y., Mao Y.;
RT   "Identification of a novel PDZ domain-containing gene.";
RL   Submitted (NOV-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), AND VARIANTS
RP   GLU-534 AND LYS-1021.
RC   TISSUE=Hippocampus, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT LYS-1021.
RC   TISSUE=Retina;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4 AND 5).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, INTERACTION WITH ARVCF; CTNND2 AND PKP4, MUTAGENESIS OF LYS-955,
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=19706687; DOI=10.1242/jcs.046854;
RA   Stenzel N., Fetzer C.P., Heumann R., Erdmann K.S.;
RT   "PDZ-domain-directed basolateral targeting of the peripheral membrane
RT   protein FRMPD2 in epithelial cells.";
RL   J. Cell Sci. 122:3374-3384(2009).
RN   [7]
RP   VARIANT [LARGE SCALE ANALYSIS] TRP-727.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
RN   [8]
RP   VARIANT ARG-351.
RX   PubMed=22068589; DOI=10.1093/hmg/ddr509;
RA   Khan K., Logan C.V., McKibbin M., Sheridan E., Elcioglu N.H., Yenice O.,
RA   Parry D.A., Fernandez-Fuentes N., Abdelhamed Z.I., Al-Maskari A.,
RA   Poulter J.A., Mohamed M.D., Carr I.M., Morgan J.E., Jafri H., Raashid Y.,
RA   Taylor G.R., Johnson C.A., Inglehearn C.F., Toomes C., Ali M.;
RT   "Next generation sequencing identifies mutations in Atonal homolog 7
RT   (ATOH7) in families with global eye developmental defects.";
RL   Hum. Mol. Genet. 21:776-783(2012).
CC   -!- FUNCTION: May play a role in the regulation of tight junction
CC       formation. Binds phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P2).
CC       {ECO:0000269|PubMed:19706687}.
CC   -!- SUBUNIT: Interacts (via the PDZ 2 domain) with CTNND2 (via the extreme
CC       C-terminus). Interacts (via the PDZ 2 domain) with PKP4 (via the
CC       extreme C-terminus); this interaction directed FRMPD2 to the
CC       basolateral membranes. Interacts (via the PDZ 2 domain) with ARVCF (via
CC       the extreme C-terminus). {ECO:0000269|PubMed:19706687}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}. Basolateral cell
CC       membrane {ECO:0000269|PubMed:19706687}. Cell junction, tight junction
CC       {ECO:0000269|PubMed:19706687}. Note=Colocalizes with CTNNB1, CDH1 and
CC       PKP4 at the basolateral membrane. Colocalizes with TJP1 at tight
CC       junctions. Its recruitment to cell-cell contacts requires CDH1.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q68DX3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q68DX3-2; Sequence=VSP_028523, VSP_028524, VSP_028527;
CC       Name=3;
CC         IsoId=Q68DX3-3; Sequence=VSP_028525, VSP_028526;
CC       Name=4;
CC         IsoId=Q68DX3-4; Sequence=VSP_028522, VSP_028528;
CC       Name=5;
CC         IsoId=Q68DX3-5; Sequence=VSP_028521;
CC   -!- TISSUE SPECIFICITY: Expressed in epithelial cells.
CC       {ECO:0000269|PubMed:19706687}.
CC   -!- DOMAIN: The FERM and PDZ 2 domains are necessary for localization to
CC       the basolateral cell membrane. The FERM domain binds to
CC       phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P2) and is sufficient
CC       for membrane localization.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY491519; AAS79660.1; -; mRNA.
DR   EMBL; AK123038; BAC85520.1; -; mRNA.
DR   EMBL; AK131386; BAD18537.1; -; mRNA.
DR   EMBL; CR749241; CAH18097.1; -; mRNA.
DR   EMBL; AC013284; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC074325; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC031614; AAH31614.1; -; mRNA.
DR   EMBL; BC073954; AAH73954.1; -; mRNA.
DR   EMBL; BC144635; AAI44636.1; -; mRNA.
DR   EMBL; BC144639; AAI44640.1; -; mRNA.
DR   CCDS; CCDS31195.1; -. [Q68DX3-1]
DR   CCDS; CCDS81460.1; -. [Q68DX3-2]
DR   RefSeq; NP_001018081.3; NM_001018071.3. [Q68DX3-1]
DR   RefSeq; NP_001035977.2; NM_001042512.2. [Q68DX3-4]
DR   RefSeq; NP_001305120.1; NM_001318191.1.
DR   RefSeq; XP_016871233.1; XM_017015744.1. [Q68DX3-5]
DR   AlphaFoldDB; Q68DX3; -.
DR   SMR; Q68DX3; -.
DR   BioGRID; 126788; 17.
DR   IntAct; Q68DX3; 2.
DR   STRING; 9606.ENSP00000363317; -.
DR   GlyGen; Q68DX3; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q68DX3; -.
DR   PhosphoSitePlus; Q68DX3; -.
DR   BioMuta; FRMPD2; -.
DR   DMDM; 334302902; -.
DR   jPOST; Q68DX3; -.
DR   MassIVE; Q68DX3; -.
DR   PaxDb; Q68DX3; -.
DR   PeptideAtlas; Q68DX3; -.
DR   ProteomicsDB; 66110; -. [Q68DX3-1]
DR   ProteomicsDB; 66111; -. [Q68DX3-2]
DR   ProteomicsDB; 66112; -. [Q68DX3-3]
DR   Antibodypedia; 13728; 79 antibodies from 21 providers.
DR   DNASU; 143162; -.
DR   Ensembl; ENST00000305531.3; ENSP00000307079.3; ENSG00000170324.21. [Q68DX3-2]
DR   Ensembl; ENST00000374201.8; ENSP00000363317.3; ENSG00000170324.21. [Q68DX3-1]
DR   GeneID; 143162; -.
DR   KEGG; hsa:143162; -.
DR   MANE-Select; ENST00000374201.8; ENSP00000363317.3; NM_001018071.4; NP_001018081.4.
DR   UCSC; uc001jgg.5; human. [Q68DX3-1]
DR   AGR; HGNC:28572; -.
DR   CTD; 143162; -.
DR   DisGeNET; 143162; -.
DR   GeneCards; FRMPD2; -.
DR   HGNC; HGNC:28572; FRMPD2.
DR   HPA; ENSG00000170324; Tissue enhanced (brain, choroid plexus, retina).
DR   MIM; 613323; gene.
DR   neXtProt; NX_Q68DX3; -.
DR   OpenTargets; ENSG00000170324; -.
DR   PharmGKB; PA134947461; -.
DR   VEuPathDB; HostDB:ENSG00000170324; -.
DR   eggNOG; KOG0792; Eukaryota.
DR   eggNOG; KOG3528; Eukaryota.
DR   GeneTree; ENSGT00940000161964; -.
DR   HOGENOM; CLU_079375_0_0_1; -.
DR   InParanoid; Q68DX3; -.
DR   OMA; LAMCEDQ; -.
DR   OrthoDB; 2910505at2759; -.
DR   PhylomeDB; Q68DX3; -.
DR   TreeFam; TF315388; -.
DR   PathwayCommons; Q68DX3; -.
DR   SignaLink; Q68DX3; -.
DR   BioGRID-ORCS; 143162; 10 hits in 1145 CRISPR screens.
DR   ChiTaRS; FRMPD2; human.
DR   GenomeRNAi; 143162; -.
DR   Pharos; Q68DX3; Tbio.
DR   PRO; PR:Q68DX3; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; Q68DX3; protein.
DR   Bgee; ENSG00000170324; Expressed in superior frontal gyrus and 95 other tissues.
DR   ExpressionAtlas; Q68DX3; baseline and differential.
DR   Genevisible; Q68DX3; HS.
DR   GO; GO:0045177; C:apical part of cell; IBA:GO_Central.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005923; C:bicellular tight junction; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005856; C:cytoskeleton; IEA:InterPro.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0005545; F:1-phosphatidylinositol binding; IDA:UniProtKB.
DR   GO; GO:0070830; P:bicellular tight junction assembly; IMP:UniProtKB.
DR   GO; GO:0031023; P:microtubule organizing center organization; IBA:GO_Central.
DR   GO; GO:0070507; P:regulation of microtubule cytoskeleton organization; IBA:GO_Central.
DR   CDD; cd14473; FERM_B-lobe; 1.
DR   CDD; cd13187; FERM_C_PTPH13; 1.
DR   CDD; cd17196; FERM_F1_FRMPD2; 1.
DR   CDD; cd00992; PDZ_signaling; 3.
DR   Gene3D; 1.20.80.10; -; 1.
DR   Gene3D; 2.30.42.10; -; 3.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR019749; Band_41_domain.
DR   InterPro; IPR014352; FERM/acyl-CoA-bd_prot_sf.
DR   InterPro; IPR035963; FERM_2.
DR   InterPro; IPR019748; FERM_central.
DR   InterPro; IPR000299; FERM_domain.
DR   InterPro; IPR018979; FERM_N.
DR   InterPro; IPR018980; FERM_PH-like_C.
DR   InterPro; IPR011019; KIND_dom.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   PANTHER; PTHR46900:SF3; NON-SPECIFIC PROTEIN-TYROSINE KINASE; 1.
DR   PANTHER; PTHR46900; TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 13; 1.
DR   Pfam; PF09380; FERM_C; 1.
DR   Pfam; PF00373; FERM_M; 1.
DR   Pfam; PF09379; FERM_N; 1.
DR   Pfam; PF00595; PDZ; 3.
DR   PRINTS; PR00935; BAND41.
DR   SMART; SM00295; B41; 1.
DR   SMART; SM01196; FERM_C; 1.
DR   SMART; SM00750; KIND; 1.
DR   SMART; SM00228; PDZ; 3.
DR   SUPFAM; SSF50156; PDZ domain-like; 3.
DR   SUPFAM; SSF50729; PH domain-like; 1.
DR   SUPFAM; SSF47031; Second domain of FERM; 1.
DR   SUPFAM; SSF54236; Ubiquitin-like; 1.
DR   PROSITE; PS50057; FERM_3; 1.
DR   PROSITE; PS51377; KIND; 1.
DR   PROSITE; PS50106; PDZ; 3.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell junction; Cell membrane; Cytoplasm; Membrane;
KW   Reference proteome; Repeat; Tight junction.
FT   CHAIN           1..1309
FT                   /note="FERM and PDZ domain-containing protein 2"
FT                   /id="PRO_0000306854"
FT   DOMAIN          15..197
FT                   /note="KIND"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00709"
FT   DOMAIN          342..642
FT                   /note="FERM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00084"
FT   DOMAIN          775..861
FT                   /note="PDZ 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          950..1035
FT                   /note="PDZ 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          1079..1167
FT                   /note="PDZ 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   REGION          214..249
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          266..302
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          859..880
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1204..1228
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        235..249
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        274..302
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         1..1048
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:15489334, ECO:0000303|Ref.1"
FT                   /id="VSP_028521"
FT   VAR_SEQ         1..989
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_028522"
FT   VAR_SEQ         1..8
FT                   /note="MQPLTKDA -> MHVFIV (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_028523"
FT   VAR_SEQ         103..124
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_028524"
FT   VAR_SEQ         391..392
FT                   /note="KE -> GE (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_028525"
FT   VAR_SEQ         393..1309
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_028526"
FT   VAR_SEQ         486
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_028527"
FT   VAR_SEQ         990..996
FT                   /note="KEGQILQ -> MTSIPFP (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_028528"
FT   VARIANT         20
FT                   /note="A -> T (in dbSNP:rs11101272)"
FT                   /id="VAR_055540"
FT   VARIANT         239
FT                   /note="T -> M (in dbSNP:rs55802136)"
FT                   /id="VAR_061034"
FT   VARIANT         351
FT                   /note="G -> R (in dbSNP:rs116143480)"
FT                   /evidence="ECO:0000269|PubMed:22068589"
FT                   /id="VAR_072402"
FT   VARIANT         534
FT                   /note="K -> E (in dbSNP:rs1864345)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_055541"
FT   VARIANT         727
FT                   /note="R -> W (in a colorectal cancer sample; somatic
FT                   mutation; dbSNP:rs115907611)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035446"
FT   VARIANT         1021
FT                   /note="T -> K (in dbSNP:rs1898784)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:17974005"
FT                   /id="VAR_065253"
FT   MUTAGEN         955
FT                   /note="K->E: Abolishes the basolateral membrane
FT                   localization."
FT                   /evidence="ECO:0000269|PubMed:19706687"
FT   CONFLICT        601
FT                   /note="K -> E (in Ref. 3; CAH18097)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        624
FT                   /note="S -> G (in Ref. 3; CAH18097)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        826
FT                   /note="I -> T (in Ref. 3; CAH18097)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        874
FT                   /note="S -> G (in Ref. 2; BAC85520)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        895
FT                   /note="L -> S (in Ref. 2; BAC85520)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        969
FT                   /note="N -> M (in Ref. 5; AAH73954/AAI44636/AAI44640)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1077
FT                   /note="K -> N (in Ref. 1; AAS79660)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1174
FT                   /note="L -> M (in Ref. 2; BAC85520)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1214
FT                   /note="S -> F (in Ref. 1; AAS79660)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1309 AA;  144282 MW;  7684E687FA8522B4 CRC64;
     MQPLTKDAGM SLSSVTLASA LQVRGEALSE EEIWSLLFLA AEQLLEDLRN DSSDYVVCPW
     SALLSAAGSL SFQGRVSHIE AAPFKAPELL QGQSEDEQPD ASQMHVYSLG MTLYWSAGFH
     VPPHQPLQLC EPLHSILLTM CEDQPHRRCT LQSVLEACRV HEKEVSVYPA PAGLHIRRLV
     GLVLGTISEV EKRVVEESSS VQQNRSYLLR KRLRGTSSES PAAQAPECLH PCRVSERSTE
     TQSSPEPHWS TLTHSHCSLL VNRALPGADP QDQQAGRRLS SGSVHSAADS SWPTTPSQRG
     FLQRRSKFSR PEFILLAGEA PMTLHLPGSV VTKKGKSYLA LRDLCVVLLN GQHLEVKCDV
     ESTVGAVFNA VTSFANLEEL TYFGLAYMKS KEFFFLDSET RLCKIAPEGW REQPQKTSMN
     TFTLFLRIKF FVSHYGLLQH SLTRHQFYLQ LRKDILEERL YCNEEILLQL GVLALQAEFG
     NYPKEQVESK PYFHVEDYIP ASLIERMTAL RVQVEVSEMH RLSSALWGED AELKFLRVTQ
     QLPEYGVLVH QVFSEKRRPE EEMALGICAK GVIVYEVKNN SRIAMLRFQW RETGKISTYQ
     KKFTITSSVT GKKHTFVTDS AKTSKYLLDL CSAQHGFNAQ MGSGQPSHVL FDHDKFVQMA
     NLSPAHQARS KPLIWIQRLS CSENELFVSR LQGAAGGLLS TSMDNFNVDG SKEAGAEGIG
     RSPCTGREQL KSACVIQKPM TWDSLSGPPV QSMHAGSKNN RRKSFIAEPG REIVRVTLKR
     DPHRGFGFVI NEGEYSGQAD PGIFISSIIP GGPAEKAKTI KPGGQILALN HISLEGFTFN
     MAVRMIQNSP DNIELIISQS KGVGGNNPDE EKNSTANSGV SSTDILSFGY QGSLLSHTQD
     QDRNTEELDM AGVQSLVPRL RHQLSFLPLK GAGSSCPPSP PEISAGEIYF VELVKEDGTL
     GFSVTGGINT SVPYGGIYVK SIVPGGPAAK EGQILQGDRL LQVDGVILCG LTHKQAVQCL
     TGPGQVARLV LERRVPRSTQ QCPSANDSMG DERTAVSLVT ALPGRPSSCV SVTDGPKFEV
     KLKKNANGLG FSFVQMEKES CSHLKSDLVR IKRLFPGQPA EENGAIAAGD IILAVNGRST
     EGLIFQEVLH LLRGAPQEVT LLLCRPPPGA LPELEQEWQT PELSADKEFT RATCTDSCTS
     PILDQEDSWR DSASPDAGEG LGLRPESSQK AIREAQWGQN RERPWASSLT HSPESHPHLC
     KLHQERDEST LATSLEKDVR QNCYSVCDIM RLGRYSFSSP LTRLSTDIF
//
